Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa: a strategy to reduce side-effects, improving patients' compliance
Br J Dermatol
.
2019 Apr;180(4):949.
doi: 10.1111/bjd.17423.
Epub 2019 Jan 1.
Authors
C Marasca
1
,
A Masarà
1
,
M C Annunziata
1
,
V Bettoli
2
,
M A Luciano
1
,
G Fabbrocini
1
Affiliations
1
Department of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Via Pansini 5, Napoli, Italy.
2
Section of Dermatology, Department of Medical Sciences, University of Ferrara, Arcispedale S. Anna, Ferrara, Italy.
PMID:
30430549
DOI:
10.1111/bjd.17423
No abstract available
Publication types
Letter
Comment
MeSH terms
Anti-Bacterial Agents
Clindamycin*
Drug Therapy, Combination
Hidradenitis Suppurativa*
Humans
Rifampin
Substances
Anti-Bacterial Agents
Clindamycin
Rifampin